We are actively seeking investments in variety of sectors, including energy, aerospace, chemicals, building products, distribution, industrial technology, healthcare manufacturing and packaging. Our philosophy is to buy competitively differentiated market leaders and aggressively grow their earnings by prioritizing innovation and capital allocation.
“The Golden Gate Capital team has brought a blend of sector-area expertise, operating knowledge, and a deep bench of talent that has accelerated the trajectory of ANGUS Chemical Company since Golden Gate completed the carve-out of the business from the Dow Chemical Company in 2015. The Golden Gate team identified an opportunity to drive growth with significant investments in ANGUS’ Life Sciences and Personal Care business segments, including major capacity expansions and the buildout of innovation and sales capabilities. These investments have enabled the company’s transformation into a high-growth, consumer-focused organization.”
– David Neuberger, CEO, ANGUS Chemical Company
*David Neuberger is not an investor in any fund sponsored by Golden Gate Private Equity, Inc. (“Golden Gate”). Mr. Neuberger has not been compensated for any statement regarding Golden Gate; however, he is employed and compensated by a Golden Gate portfolio company and, given his position therewith, may nevertheless feel influenced or incentivized to make positive statements about Golden Gate.